a Indian Institute of Vegetable Research (ICAR) , Varanasi , India.
J Environ Sci Health B. 2014;49(2):134-41. doi: 10.1080/03601234.2014.847257.
This paper reports the in vitro and in vivo bioefficacy of a combination fungicide trifloxystrobin (25%) + tebuconazole (50%) against early blight disease of tomato (Lycopersicon esculentum Mill.) caused by Alternaria solani and their corresponding pre-harvest intervals (PHI) with reference to the maximum residue limits (European Union). Bioefficacy of the test fungicide combination revealed that in vitro conditions manifested the best control (75.1%) at 350 mg kg(-1) against 76.2% control under field conditions. A sample preparation method based on ethyl acetate extraction and estimation by LC-MS multiple reaction monitoring (MRM) was validated in tomato fruits at 0.01 mg/kg and dissipation studies were conducted in field at single and double doses. The residues of both the compounds on all the sampling days were below the European Union maximum residue limits (EU-MRLs) and the maximum permissible intakes (MPIs) were calculated on the basis of prescribed acceptable daily intake (ADI). The combined bioefficacy and residue dynamics information will support label-claim of this fungicide combination for the management of early blight in tomato.
本研究报告了一种复配杀菌剂三氟醚菌唑(25%)+戊唑醇(50%)对早疫病(由茄链格孢引起)的离体和活体生物功效,以及参照最大残留限量(欧盟)得出的相应采前间隔期(PHI)。试验杀菌剂复配物的生物功效表明,在 350mgkg-1 离体条件下,对 76.2%的田间对照具有最佳防治效果(75.1%)。在番茄果实中验证了一种基于乙酸乙酯提取和 LC-MS 多重反应监测(MRM)估计的样品制备方法,在田间进行了单剂和双剂消解研究。所有采样日的两种化合物残留均低于欧盟最大残留限量(EU-MRLs),并根据规定的每日允许摄入量(ADI)计算了最大允许摄入量(MPI)。综合生物功效和残留动态信息将支持该杀菌剂复配物用于防治番茄早疫病的标签声明。